CVE-2008-6269

Public Exploit

Description

Joovili 3.1.4 allows remote attackers to bypass authentication and gain privileges as other users, including the administrator, by setting the (1) session_id, session_logged_in, and session_username cookies for user privileges; (2) session_admin_id, session_admin_username, and session_admin cookies for admin privileges; and (3) session_staff_id, session_staff_username, and session_staff cookies for staff users.

Category

7.5
CVSS
Severity: High
CVSS 2.0 •
EPSS 2.38% Top 20%
Vendor Advisory secunia.com Vendor Advisory vupen.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://exchange.xforce.ibmcloud.com/vulnerabilities/46272 vdb entry
http://secunia.com/advisories/32491 third party advisory vendor advisory
https://www.exploit-db.com/exploits/6955 exploit
http://www.securityfocus.com/bid/32058 vdb entry exploit
http://www.vupen.com/english/advisories/2008/2978 vdb entry vendor advisory

Frequently Asked Questions

What is the severity of CVE-2008-6269?
CVE-2008-6269 has been scored as a high severity vulnerability.
How to fix CVE-2008-6269?
To fix CVE-2008-6269, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-6269 being actively exploited in the wild?
It is possible that CVE-2008-6269 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.